These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A 18F-labeled BF-227 derivative as a potential radioligand for imaging dense amyloid plaques by positron emission tomography. Furumoto S; Okamura N; Furukawa K; Tashiro M; Ishikawa Y; Sugi K; Tomita N; Waragai M; Harada R; Tago T; Iwata R; Yanai K; Arai H; Kudo Y Mol Imaging Biol; 2013 Aug; 15(4):497-506. PubMed ID: 23362000 [TBL] [Abstract][Full Text] [Related]
23. Styrylbenzoxazole derivatives for in vivo imaging of amyloid plaques in the brain. Okamura N; Suemoto T; Shimadzu H; Suzuki M; Shiomitsu T; Akatsu H; Yamamoto T; Staufenbiel M; Yanai K; Arai H; Sasaki H; Kudo Y; Sawada T J Neurosci; 2004 Mar; 24(10):2535-41. PubMed ID: 15014129 [TBL] [Abstract][Full Text] [Related]
24. Validation by Magnetic Resonance Imaging of the Diagnostic Potential of a Heptapeptide-Functionalized Imaging Probe Targeted to Amyloid-β and Able to Cross the Blood-Brain Barrier. André S; Ansciaux E; Saidi E; Larbanoix L; Stanicki D; Nonclercq D; Vander Elst L; Laurent S; Muller RN; Burtea C J Alzheimers Dis; 2017; 60(4):1547-1565. PubMed ID: 29036827 [TBL] [Abstract][Full Text] [Related]
25. Biological evaluation of the radioiodinated imidazo[1,2-a]pyridine derivative DRK092 for amyloid-β imaging in mouse model of Alzheimer's disease. Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Morimoto Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Suhara T; Higuchi M; Yamada K; Ji B Neurosci Lett; 2014 Oct; 581():103-8. PubMed ID: 25172571 [TBL] [Abstract][Full Text] [Related]
26. Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer's disease. Ikonomovic MD; Buckley CJ; Abrahamson EE; Kofler JK; Mathis CA; Klunk WE; Farrar G Acta Neuropathol; 2020 Oct; 140(4):463-476. PubMed ID: 32772265 [TBL] [Abstract][Full Text] [Related]
27. Development of novel 123I-labeled pyridyl benzofuran derivatives for SPECT imaging of β-amyloid plaques in Alzheimer's disease. Ono M; Cheng Y; Kimura H; Watanabe H; Matsumura K; Yoshimura M; Iikuni S; Okamoto Y; Ihara M; Takahashi R; Saji H PLoS One; 2013; 8(9):e74104. PubMed ID: 24058519 [TBL] [Abstract][Full Text] [Related]
28. Superparamagnetic nanoparticle-enhanced MRI of Alzheimer's disease plaques and activated microglia in 3X transgenic mouse brains: Contrast optimization. Tafoya MA; Madi S; Sillerud LO J Magn Reson Imaging; 2017 Aug; 46(2):574-588. PubMed ID: 27875002 [TBL] [Abstract][Full Text] [Related]
29. Clinical field-strength MRI of amyloid plaques induced by low-level cholesterol feeding in rabbits. Ronald JA; Chen Y; Bernas L; Kitzler HH; Rogers KA; Hegele RA; Rutt BK Brain; 2009 May; 132(Pt 5):1346-54. PubMed ID: 19293239 [TBL] [Abstract][Full Text] [Related]
30. Molecular Design of Magnetic Resonance Imaging Agents Binding to Amyloid Deposits. Nikiforova A; Sedov I Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446329 [TBL] [Abstract][Full Text] [Related]
31. AZD2184: a radioligand for sensitive detection of beta-amyloid deposits. Johnson AE; Jeppsson F; Sandell J; Wensbo D; Neelissen JA; Juréus A; Ström P; Norman H; Farde L; Svensson SP J Neurochem; 2009 Mar; 108(5):1177-86. PubMed ID: 19141073 [TBL] [Abstract][Full Text] [Related]
33. Amyloid imaging using fluorine-19 magnetic resonance imaging ((19)F-MRI). Tooyama I; Yanagisawa D; Taguchi H; Kato T; Hirao K; Shirai N; Sogabe T; Ibrahim NF; Inubushi T; Morikawa S Ageing Res Rev; 2016 Sep; 30():85-94. PubMed ID: 26772439 [TBL] [Abstract][Full Text] [Related]
34. Efficient near-infrared in vivo imaging of amyoid-β deposits in Alzheimer's disease mouse models. Schmidt A; Pahnke J J Alzheimers Dis; 2012; 30(3):651-64. PubMed ID: 22460331 [TBL] [Abstract][Full Text] [Related]
35. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging. Wadghiri YZ; Sigurdsson EM; Sadowski M; Elliott JI; Li Y; Scholtzova H; Tang CY; Aguinaldo G; Pappolla M; Duff K; Wisniewski T; Turnbull DH Magn Reson Med; 2003 Aug; 50(2):293-302. PubMed ID: 12876705 [TBL] [Abstract][Full Text] [Related]
36. PET imaging of amyloid in Alzheimer's disease. Nordberg A Lancet Neurol; 2004 Sep; 3(9):519-27. PubMed ID: 15324720 [TBL] [Abstract][Full Text] [Related]
37. Characterization of IMPY as a potential imaging agent for beta-amyloid plaques in double transgenic PSAPP mice. Kung MP; Hou C; Zhuang ZP; Cross AJ; Maier DL; Kung HF Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1136-45. PubMed ID: 15007564 [TBL] [Abstract][Full Text] [Related]
38. Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients. Kung MP; Skovronsky DM; Hou C; Zhuang ZP; Gur TL; Zhang B; Trojanowski JQ; Lee VM; Kung HF J Mol Neurosci; 2003 Feb; 20(1):15-24. PubMed ID: 12663930 [TBL] [Abstract][Full Text] [Related]
39. Visualization of beta-amyloid plaques in a transgenic mouse model of Alzheimer's disease using MR microscopy without contrast reagents. Lee SP; Falangola MF; Nixon RA; Duff K; Helpern JA Magn Reson Med; 2004 Sep; 52(3):538-44. PubMed ID: 15334572 [TBL] [Abstract][Full Text] [Related]
40. Magnetic resonance imaging of amyloid plaques using hollow manganese oxide nanoparticles conjugated with antibody aβ1-40 in a transgenic mouse model. Kim JH; Ha TL; Im GH; Yang J; Seo SW; Lee IS; Lee JH Neuroreport; 2013 Jan; 24(1):16-21. PubMed ID: 23168564 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]